High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE)

NCT03217903 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

High-risk Myelodysplastic Syndromes With Excess Blasts

Interventions

DIAGNOSTIC_TEST: Myelogram

Sponsor

Central Hospital, Nancy, France

Collaborators

[object Object]